Simvastatin induces glutathione (GSH)-mediated suppression of ABCG4 (which causes efflux of intracellular doxorubicin and cisplatin) levels, increasing the sensitivity of prostate cancer cells to cisplatin and leading to the suppression of tumor growth [98]. The gene discussed is ABCG4; the disease is neoplasm.